BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31159506)

  • 1. Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine.
    Savastano M; Bazzicalupi C; Ferraro G; Fratini E; Gratteri P; Bianchi A
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31159506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr
    Savastano M; Boscaro F; Bianchi A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV).
    Toporivska Y; Gumienna-Kontecka E
    J Inorg Biochem; 2019 Sep; 198():110753. PubMed ID: 31229836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Thermodynamic Stability of Zirconium Radiotracers.
    Holland JP
    Inorg Chem; 2020 Feb; 59(3):2070-2082. PubMed ID: 31940188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
    Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.
    Guérard F; Lee YS; Tripier R; Szajek LP; Deschamps JR; Brechbiel MW
    Chem Commun (Camb); 2013 Feb; 49(10):1002-4. PubMed ID: 23250287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
    Sarbisheh EK; Salih AK; Raheem SJ; Lewis JS; Price EW
    Inorg Chem; 2020 Aug; 59(16):11715-11727. PubMed ID: 32799484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
    Guérard F; Lee YS; Brechbiel MW
    Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
    Seibold U; Wängler B; Wängler C
    ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.
    Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ
    Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
    Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
    J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
    Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
    Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
    Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes.
    Patra M; Bauman A; Mari C; Fischer CA; Blacque O; Häussinger D; Gasser G; Mindt TL
    Chem Commun (Camb); 2014 Oct; 50(78):11523-5. PubMed ID: 25132321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
    Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
    Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design.
    Holland JP; Vasdev N
    Dalton Trans; 2014 Jul; 43(26):9872-84. PubMed ID: 24722728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic versus Noncyclic Chelating Scaffold for
    Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
    Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Modular Desferrioxamine Analogues and Evaluation of Zwitterionic Derivatives for Zirconium Complexation.
    Outzen L; Münzmay M; Frangioni JV; Maison W
    ChemMedChem; 2023 Jul; 18(13):e202300112. PubMed ID: 37057615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.